Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

(2018) Verena Niederberger et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent

(2017) Margitta Worm et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation

(2017) Krzysztof Buczyłko et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients

(2016) O. Pfaar et al.   ALLERGY

The Role of Allergen Immunotherapy in the Management of Allergic Rhinitis

(2016) Linda Cox   American Journal of Rhinology & Allergy

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1–derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study

(2016) François Spertini et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics

(2016) Marek Jutel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy

(2016) Petra Zieglmayer et al.   EBioMedicine

Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease

(2015) Kiran Dallenbach et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy

(2015) Margarete Focke-Tejkl et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

High-Density IgE Recognition of the Major Grass Pollen Allergen Phl p 1 Revealed with Single-Chain IgE Antibody Fragments Obtained by Combinatorial Cloning

(2015) Christoph Madritsch et al.   JOURNAL OF IMMUNOLOGY

Safety and immunogenicity of immunotherapy with Bet v 1–derived contiguous overlapping peptides

(2014) François Spertini et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rapid development of broadly influenza neutralizing antibodies through redundant mutations

(2014) Leontios Pappas et al.   NATURE

Possible therapeutic potential of a recombinant group 2 grass pollen allergen-specific antibody fragment

(2013) E. Gadermaier et al.   ALLERGY

Allergen specificity of IgG4-expressing B cells in patients with grass pollen allergy undergoing immunotherapy

(2012) Louisa K. James et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mapping of Conformational IgE Epitopes with Peptide-Specific Monoclonal Antibodies Reveals Simultaneous Binding of Different IgE Antibodies to a Surface Patch on the Major Birch Pollen Allergen, Bet v 1

(2011) A. Gieras et al.   JOURNAL OF IMMUNOLOGY

MMDB: 3D structures and macromolecular interactions

(2011) T. Madej et al.   NUCLEIC ACIDS RESEARCH

Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives

(2011) Birgit Linhart et al.   VACCINE

Trimolecular Complex Formation of IgE, Fc RI, and a Recombinant Nonanaphylactic Single-Chain Antibody Fragment with High Affinity for IgE

(2009) C. Lupinek et al.   JOURNAL OF IMMUNOLOGY

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

(2008) X. Brochet et al.   NUCLEIC ACIDS RESEARCH